Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum 2023-01-03 23:25
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test 2023-01-03 22:24
Exclusive Pepaminto topper wins CES® 2023 Innovation Award 2023-01-03 22:00
Bridge Biotherapeutics to Present at BIOTECH SHOWCASE™ 2023 2023-01-03 22:00
Sisram Medical to Present Virtually at the 25th Annual Needham Growth Conference 2023-01-03 21:30
Call for Application for 2023 Tsinghua Amgen Scholars Program 2023-01-03 21:20
Steakholder Foods® Receives Grant of up to $1M for Collaboration with Umami Meats to 3D Bio-Print Structured Cultivated Fish Products 2023-01-03 20:00
ProfoundBio Announces Initiation of First-in-Human Trial for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Receives FDA "Study May Proceed" Letter for PRO1160, a CD70-Directed ADC 2023-01-03 20:00
Clarivate and the Chinese Academy of Sciences Release Annual Joint Report to Identify 165 Research Fronts 2023-01-03 16:02
Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company 2023-01-03 16:00
Antengene to Present at the 41st Annual J.P. Morgan Healthcare Conference 2023-01-03 14:10
Bayer Taiwan Company Ltd. and Berocca Honored at the Asia Pacific Enterprise Awards 2022 Taiwan 2023-01-03 10:05
CGTN: China monitors coronavirus mutations to adjust COVID-19 response 2023-01-03 08:27
CStone announces the registrational clinical trial of sugemalimab as first-line treatment in patients with esophageal squamous cell carcinoma met primary endpoints and plans to submit a supplemental NDA to NMPA 2023-01-03 08:10
CGTN: Xi Jinping salutes ordinary people's extraordinary efforts in New Year Address 2023-01-03 07:52
CGTN:How do emergency wards in China cope with increasing COVID patients? 2023-01-03 06:54
Ascletis Believes that the Complaints Made by Viking Therapeutics Have No Merit and will Vigorously Defend Against such Complaints 2023-01-02 19:24
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates 2022-12-30 21:00
Mentice AB (publ) receives an order of USD 540,000 for simulation solutions from Corewell Health, Grand Rapids, Michigan, USA 2022-12-30 20:53
Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19 2022-12-30 13:23
1 216 217 218 219 220 1502